Athens– Saudi Food and Drug Authority (SFDA) has participated in the meetings of the International Council for Harmonisation of Technical Requirements for Pharmaceuticals for Human Use (ICH), held recently in the Greek capital, Athens, with the participation of more than 30 ICH members representing global regulators and pharmaceutical industry institutions.
The SFDA was represented in the meetings by the Executive Vice President of the Pharmaceutical Sector, Dr. Adel bin Abdullah Al-Harf, the Executive Director of Regulatory Affairs in the Pharmaceutical Sector, Abdullah bin Hamad Al-Hatareshah, and the Director of the Standards Department, Yahya bin Ibrahim Al-Nujaim.
The meetings discussed regulatory aspects in the global pharmaceutical industries, including accreditation and global regulatory convergence, broadening regulatory horizons about medicine, and looking towards regulatory innovation and guidelines, in addition to other topics proposed and submitted by member states and cast them for a vote.
Source: Saudi Press Agency